User profiles for Jumpei Ito

Jumpei Ito

Division of Systems Virology, Institute of Medical Science, The University of Tokyo
Verified email at g.ecc.u-tokyo.ac.jp
Cited by 5448

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

…, D Yamasoba, I Kimura, L Wang, M Kishimoto, J Ito… - Nature, 2022 - nature.com
The emergence of the Omicron variant of SARS-CoV-2 is an urgent global health concern 1
. In this study, our statistical modelling suggests that Omicron has spread more rapidly than …

Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation

…, I Kimura, J Ito, J Wu, K Iwatsuki-Horimoto, M Ito… - Nature, 2022 - nature.com
During the current coronavirus disease 2019 (COVID-19) pandemic, a variety of mutations
have accumulated in the viral genome of severe acute respiratory syndrome coronavirus 2 (…

Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ. 1.1 variant

J Ito, R Suzuki, K Uriu, Y Itakura, J Zahradnik… - Nature …, 2023 - nature.com
In late 2022, various Omicron subvariants emerged and cocirculated worldwide. These
variants convergently acquired amino acid substitutions at critical residues in the spike protein, …

Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants

T Tamura, J Ito, K Uriu, J Zahradnik, I Kida… - Nature …, 2023 - nature.com
In late 2022, SARS-CoV-2 Omicron subvariants have become highly diversified, and XBB is
spreading rapidly around the world. Our phylogenetic analyses suggested that XBB …

[HTML][HTML] SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity

…, I Kimura, K Uriu, Y Kosugi, Y Yue, R Shimizu, J Ito… - Cell host & …, 2021 - cell.com
Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These
mutations can affect viral properties such as infectivity and immune resistance. Although the …

[HTML][HTML] Virological characteristics of the SARS-CoV-2 Omicron BA. 2 spike

…, I Kimura, H Nasser, Y Morioka, N Nao, J Ito… - Cell, 2022 - cell.com
Soon after the emergence and global spread of the SARS-CoV-2 Omicron lineage BA.1,
another Omicron lineage, BA.2, began outcompeting BA.1. The results of statistical analysis …

Virological characteristics of the SARS-CoV-2 Omicron BA. 2 subvariants, including BA. 4 and BA. 5

…, T Tamura, N Nao, T Suzuki, Y Oda, S Mitoma, J Ito… - Cell, 2022 - cell.com
After the global spread of the SARS-CoV-2 Omicron BA.2, some BA.2 subvariants, including
BA.2.9.1, BA.2.11, BA.2.12.1, BA.4, and BA.5, emerged in multiple countries. Our statistical …

Crystal structure of the channelrhodopsin light-gated cation channel

…, C Ramakrishnan, T Nishizawa, K Hirata, J Ito… - Nature, 2012 - nature.com
Channelrhodopsins (ChRs) are light-gated cation channels derived from algae that have
shown experimental utility in optogenetics; for example, neurons expressing ChRs can be …

Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies

…, Y Kosugi, I Kimura, S Fujita, K Uriu, J Ito… - The Lancet Infectious …, 2022 - thelancet.com
2 Kimura I, Kosugi Y, Wu J, et al. The SARS-CoV-2 lambda variant exhibits enhanced infectivity
and immune resistance. Cell Rep 2022; 38: 110218. 3 Bruel T, Hadjadj J, Maes P, et al. …

Virological characteristics of the SARS-CoV-2 JN. 1 variant

…, K Kobiyama, KJ Ishii, J Zahradnik, J Ito… - The Lancet Infectious …, 2024 - thelancet.com
… 7 Uriu K, Ito J, Zahradnik J, et al. Enhanced transmissibility, infectivity, and immune
resistance of the SARS-CoV-2 omicron XBB.1.5 variant. Lancet Infect Dis 2023; 23: 280–81. …